Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07495592

The Acute Effects of Onnit Alpha Brain on Cognition and Mood States

The Acute Effects of Onnit Alpha Brain on Cognition and Mood States: A Randomized, Crossover, Double Blind, Placebo-Controlled Trial

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
34 (estimated)
Sponsor
Applied Science & Performance Institute · Industry
Sex
All
Age
20 Years – 59 Years
Healthy volunteers
Accepted

Summary

The purpose of this randomized, double-blind, placebo-controlled crossover study is to evaluate the efficacy of the acute effects of an investigational supplement (Alpha Brain or Alpha Brain 2.0) on improving cognitive performance, vigilance, and subjective mood in healthy adults compared to placebo during a period of acute sleep deprivation under conditions of controlled sleep deprivation.

Detailed description

Participants will complete three experimental conditions in a randomized order: Alpha Brain, Alpha Brain 2.0, and placebo. To avoid any possible crossover bias created by ingesting the supplements, the subjects should be appropriately counterbalanced using six possible sequences that all subjects will be equally shuffled through to help limit any bias. Each condition will be separated by a minimum 3-day washout period. Participants will undergo standardized cognitive testing, mood assessments, and safety monitoring following overnight sleep restriction. Primary outcomes include objective measures of vigilance and cognitive control, while secondary outcomes include subjective fatigue, mood state, and physiological safety measures.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTAlpha Brain proprietary cognitive dietary supplementAlpha Brain is a proprietary investigational dietary supplement. The formulation contains a combination of dietary ingredients commonly used in cognitive supplement mixes.
DIETARY_SUPPLEMENTAlpha Brain 2.0 proprietary cognitive dietary supplementAlpha Brain 2.0 is a proprietary investigational dietary supplement. The formulation contains a combination of dietary ingredients commonly used in cognitive supplements and will be evaluated under double-blind conditions in a randomized, placebo-controlled crossover study.
DIETARY_SUPPLEMENTControlled PlaceboThe placebo consists of an inactive placebo mix administered orally as two capsules.

Timeline

Start date
2026-04-16
Primary completion
2026-08-01
Completion
2026-08-15
First posted
2026-03-27
Last updated
2026-04-03

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT07495592. Inclusion in this directory is not an endorsement.